798 results on '"Rhee, Chanu"'
Search Results
52. 2274. Trends in Empiric Antibiotic Utilization for Patients Hospitalized with Community-Onset SARS-CoV-2 Infections and Viral Sepsis During the COVID-19 Pandemic
53. 320. Heterogeneity in Clinical Presentations of Sepsis
54. Is Nosocomial SARS-CoV-2 Still Worth Preventing?
55. The authors’ reply to Schaffzin et al’s Letter to the Editor
56. Improving Sepsis Outcomes in the Era of Pay-for-Performance and Electronic Quality Measures: A Joint IDSA/ACEP/PIDS/SHEA/SHM/SIDP Position Paper
57. Impact of Intravenous Immunoglobulin on Survival in Necrotizing Fasciitis With Vasopressor-Dependent Shock: A Propensity Score–Matched Analysis From 130 US Hospitals
58. Population sepsis incidence, mortality, and trends in Hong Kong between 2009–2018 using clinical and administrative data
59. Risk of Misleading Conclusions in Observational Studies of Time-to-Antibiotics and Mortality in Suspected Sepsis
60. Impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Prevention Measures on Non-SARS-CoV-2 Hospital-Onset Respiratory Viral Infections: An Incidence Trend Analysis From 2015–2023
61. In Support of Universal Admission Testing for SARS-CoV-2 During Significant Community Transmission
62. Do Prolonged Infusions of β-Lactam Antibiotics Improve Outcomes in Critically Ill Patients With Sepsis?
63. Discontinuation of Universal Admission Testing for SARS-CoV-2 and Hospital-Onset COVID-19 Infections in England and Scotland
64. Association between stopping universal SARS-CoV-2 admission testing and hospital-onset SARS-CoV-2 in England and Scotland
65. Does Severe Acute Respiratory Syndrome Coronavirus 2 Cause Sepsis?
66. New Sepsis and Septic Shock Definitions: Clinical Implications and Controversies
67. In Support of Universal Admission Testing for SARS-CoV-2 During Significant Community Transmission.
68. Impact of SARS-CoV-2 Prevention Measures on Non-SARS-CoV-2 Hospital-Onset Respiratory Viral Infections: An Incidence Trend Analysis From 2015–2023.
69. Restarting Essential Surgery in the Era of COVID-19: A Cautious Data Driven Approach Based on the Literature and Local Data
70. The Eye-Popping Costs Associated With Sepsis Diagnoses Among Medicare Beneficiaries*
71. Epidemiology of Hospital-Onset Versus Community-Onset Sepsis in U.S. Hospitals and Association With Mortality: A Retrospective Analysis Using Electronic Clinical Data
72. Current Sepsis Mandates Are Overly Prescriptive, and Some Aspects May Be Harmful
73. Incidence and Outcomes of Non–Ventilator-Associated Hospital-Acquired Pneumonia in 284 US Hospitals Using Electronic Surveillance Criteria
74. Impact of changing case definitions for coronavirus disease 2019 (COVID-19) hospitalization on pandemic metrics
75. Mycobacterium abscessus Cluster in Cardiac Surgery Patients Potentially Attributable to a Commercial Water Purification System
76. Synergy, Salary, and Satisfaction: Benefits of Training in Critical Care Medicine and Infectious Diseases Gleaned From a National Pilot Survey of Dually Trained Physicians
77. Impact of Policies on the Rise in Sepsis Incidence, 2000–2010
78. Healthcare-associated infections and conditions in the era of digital measurement
79. The authors reply
80. Does Obesity Protect Against Death in Sepsis? A Retrospective Cohort Study of 55,038 Adult Patients*
81. Variation in Identifying Sepsis and Organ Dysfunction Using Administrative Versus Electronic Clinical Data and Impact on Hospital Outcome Comparisons*
82. Sepsis Surveillance Using Adult Sepsis Events Simplified eSOFA Criteria Versus Sepsis-3 Sequential Organ Failure Assessment Criteria*
83. Association between negative-pressure room utilization and hospital-acquired Aspergillusrates in patients with coronavirus disease 2019 (COVID-19) in two academic hospitals
84. The Importance of Shifting Sepsis Quality Measures From Processes to Outcomes
85. Measuring Diagnostic Accuracy for Infection in Patients Treated for Sepsis: An Important but Challenging Exercise
86. Update on Sepsis Epidemiology in the Era of COVID-19
87. Prevalence, risk factors, and outcomes associated with delayed second doses of antibiotics in sepsis at a large academic medical center
88. Development and evaluation of a structured guide to assess the preventability of hospital-onset bacteremia and fungemia
89. 1184: PREVALENCE, RISK FACTORS, AND OUTCOMES ASSOCIATED WITH DELAYED SECOND DOSES OF ANTIBIOTICS IN SEPSIS
90. 1462. Validating a claims-based algorithm for Lyme Disease in Massachusetts
91. Critical Care Medicine and Infectious Diseases: An Emerging Combined Subspecialty in the United States
92. Comparison of Trends in Sepsis Incidence and Coding Using Administrative Claims Versus Objective Clinical Data
93. Using Procalcitonin to Guide Antibiotic Therapy
94. Presenting Symptoms Independently Predict Mortality in Septic Shock: Importance of a Previously Unmeasured Confounder*
95. Compliance With the National SEP-1 Quality Measure and Association With Sepsis Outcomes: A Multicenter Retrospective Cohort Study*
96. 1411: SEPSIS SURVEILLANCE USING SOFA VERSUS ESOFA CRITERIA BASED ON ROUTINE EHR DATA
97. 43: DIFFICULT-TO-TREAT RESISTANCE IN GRAM-NEGATIVE BACTEREMIA AMONG ICU INPATIENTS AT 162 U.S. HOSPITALS
98. 1: COMPLIANCE WITH THE SEP-1 MEASURE IS NOT ASSOCIATED WITH BETTER SEPSIS OUTCOMES
99. Early Discontinuation of Antibiotics in Patients Admitted With Clinically Suspected Serious Infection but Negative Cultures: Retrospective Cohort Study of Practice Patterns and Outcomes at 111 US Hospitals.
100. Electronic surveillance criteria for non–ventilator-associated hospital-acquired pneumonia: Assessment of reliability and validity
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.